HRP20090447T1 - Farmaceutski pripravci koji sadrže diaminooksidazu - Google Patents
Farmaceutski pripravci koji sadrže diaminooksidazu Download PDFInfo
- Publication number
- HRP20090447T1 HRP20090447T1 HR20090447T HRP20090447T HRP20090447T1 HR P20090447 T1 HRP20090447 T1 HR P20090447T1 HR 20090447 T HR20090447 T HR 20090447T HR P20090447 T HRP20090447 T HR P20090447T HR P20090447 T1 HRP20090447 T1 HR P20090447T1
- Authority
- HR
- Croatia
- Prior art keywords
- drug
- preparation
- diamine oxidase
- gastric acid
- oral
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims abstract 8
- 229960001340 histamine Drugs 0.000 claims abstract 4
- 102000016893 Amine Oxidase (Copper-Containing) Human genes 0.000 claims 11
- 108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 11
- 229940079593 drug Drugs 0.000 claims 11
- 210000004211 gastric acid Anatomy 0.000 claims 7
- 239000002552 dosage form Substances 0.000 claims 6
- 208000024780 Urticaria Diseases 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 239000006187 pill Substances 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010052568 Urticaria chronic Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000024376 chronic urticaria Diseases 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000000378 dietary effect Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 102000004316 Oxidoreductases Human genes 0.000 abstract 1
- 108090000854 Oxidoreductases Proteins 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
- C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
- C12Y104/03006—Amine oxidase (copper-containing)(1.4.3.6)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0115004A AT502098B8 (de) | 2004-07-07 | 2004-07-07 | Diaminooxidase-hältige zusammensetzung |
| PCT/EP2005/053234 WO2006003213A1 (de) | 2004-07-07 | 2005-07-06 | Pharmazeutische zusammensetzungen, die diaminooxidase enthalten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090447T1 true HRP20090447T1 (hr) | 2009-11-30 |
Family
ID=34971770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090447T HRP20090447T1 (hr) | 2004-07-07 | 2009-08-20 | Farmaceutski pripravci koji sadrže diaminooksidazu |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20080193491A1 (ja) |
| EP (2) | EP1763363B1 (ja) |
| JP (1) | JP4959558B2 (ja) |
| KR (1) | KR101367232B1 (ja) |
| CN (1) | CN1980689A (ja) |
| AT (4) | AT502098B8 (ja) |
| AU (1) | AU2005259167B2 (ja) |
| BR (1) | BRPI0513133B1 (ja) |
| CA (1) | CA2571463C (ja) |
| CY (1) | CY1109351T1 (ja) |
| DE (2) | DE502005009568D1 (ja) |
| DK (1) | DK1763363T3 (ja) |
| ES (1) | ES2326421T3 (ja) |
| HR (1) | HRP20090447T1 (ja) |
| MX (1) | MXPA06015036A (ja) |
| PL (1) | PL1763363T3 (ja) |
| PT (1) | PT1763363E (ja) |
| RS (1) | RS51183B (ja) |
| SI (1) | SI1763363T1 (ja) |
| WO (1) | WO2006003213A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2388395B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención de la fibromialgia o la fatiga crónica. |
| US20170020993A1 (en) * | 2011-03-18 | 2017-01-26 | Dr Healthcare España, S.L. | Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
| ES2388166B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Alimentos funcionales que contienen diaminooxidasa y sus usos. |
| US20160024481A1 (en) * | 2011-03-18 | 2016-01-28 | Dr Healthcare España, S.L. | Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
| ES2388515B1 (es) | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para la prevención de los síntomas de la resaca. |
| ES2387973B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor. |
| EP2694098B1 (en) * | 2011-04-07 | 2018-09-26 | Histapharm Inc. | Oral enzyme compositions for intestinal delivery |
| ES2426539B1 (es) | 2012-04-18 | 2014-09-09 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd) |
| WO2019126200A1 (en) * | 2017-12-21 | 2019-06-27 | Pepsico, Inc. | Multi-ingredient ephemeral beverage pod for making a beverage |
| SG11202107659SA (en) | 2019-02-19 | 2021-09-29 | Univ Wien Med | New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB479487A (en) * | 1935-08-01 | 1938-02-04 | Ig Farbenindustrie Ag | Manufacture of stable therapeutic products from intestinal mucous membrane |
| NL6815177A (ja) * | 1968-10-24 | 1970-04-28 | ||
| GB1318884A (en) * | 1969-07-29 | 1973-05-31 | Hydrovane Compressor | Rotary compressors |
| FR2101095A1 (en) * | 1970-08-20 | 1972-03-31 | Merieux Inst | Diamine oxidase from human placenta - for treatment of hyperhistamina |
| US3639579A (en) * | 1970-12-10 | 1972-02-01 | Matthew C Urbin | Pharmaceutical preparation |
| FR2215944A1 (en) * | 1973-02-01 | 1974-08-30 | Bellon Labor Sa Roger | Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies |
| FR2529463B1 (fr) * | 1982-07-05 | 1986-01-10 | Centre Nat Rech Scient | Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus |
| GB8319540D0 (en) * | 1983-07-20 | 1983-08-24 | Bovril Ltd | Amine removal |
| US4725540A (en) * | 1984-07-09 | 1988-02-16 | Emil Underberg | Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material |
| US5270033A (en) * | 1991-11-25 | 1993-12-14 | Montgomery Robert E | Antimicrobial composition and method of making same |
| EP1135112B1 (en) * | 1998-11-27 | 2004-10-20 | TAKADA, Kanji | An oral formulation for gastrointestinal drug delivery |
| JP4839506B2 (ja) | 2000-04-28 | 2011-12-21 | ダイキン工業株式会社 | ドライエッチング方法 |
| JP4592041B2 (ja) * | 2000-11-24 | 2010-12-01 | 株式会社Ｎｒｌファーマ | 生活の質を改善する新規食品の製造法および用途 |
| IT1317067B1 (it) * | 2000-11-29 | 2003-05-26 | Univ Roma | Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico. |
| WO2002066669A1 (en) * | 2001-02-23 | 2002-08-29 | Biovitrum Ab | Method for purification of soluble ssao |
| JP2003212773A (ja) * | 2002-01-04 | 2003-07-30 | Oramon Arzneimittel Gmbh | セチリジン及びロラタジンの局所医薬組成物 |
| DE10239029A1 (de) | 2002-08-21 | 2004-03-04 | Coty B.V. | Kosmetische und dermatologische Zubereitung mit Proteinen zur Hautaufhellung |
| JP2004167178A (ja) * | 2002-11-15 | 2004-06-17 | Masashi Takahashi | タン白質の経口投与法 |
-
2004
- 2004-07-07 AT AT0115004A patent/AT502098B8/de not_active IP Right Cessation
-
2005
- 2005-07-06 CA CA2571463A patent/CA2571463C/en active Active
- 2005-07-06 WO PCT/EP2005/053234 patent/WO2006003213A1/de active Application Filing
- 2005-07-06 PT PT05758617T patent/PT1763363E/pt unknown
- 2005-07-06 US US11/571,732 patent/US20080193491A1/en not_active Abandoned
- 2005-07-06 ES ES05758617T patent/ES2326421T3/es active Active
- 2005-07-06 MX MXPA06015036A patent/MXPA06015036A/es active IP Right Grant
- 2005-07-06 AT AT05758617T patent/ATE432710T1/de active
- 2005-07-06 DE DE502005009568T patent/DE502005009568D1/de active Active
- 2005-07-06 DE DE502005007425T patent/DE502005007425D1/de active Active
- 2005-07-06 JP JP2007519799A patent/JP4959558B2/ja not_active Expired - Fee Related
- 2005-07-06 EP EP05758617A patent/EP1763363B1/de active Active
- 2005-07-06 BR BRPI0513133A patent/BRPI0513133B1/pt not_active IP Right Cessation
- 2005-07-06 DK DK05758617T patent/DK1763363T3/da active
- 2005-07-06 KR KR1020077002826A patent/KR101367232B1/ko not_active IP Right Cessation
- 2005-07-06 AU AU2005259167A patent/AU2005259167B2/en not_active Ceased
- 2005-07-06 RS RSP-2009/0371A patent/RS51183B/sr unknown
- 2005-07-06 AT AT07101239T patent/ATE467423T1/de active
- 2005-07-06 CN CNA2005800227917A patent/CN1980689A/zh active Pending
- 2005-07-06 SI SI200530749T patent/SI1763363T1/sl unknown
- 2005-07-06 PL PL05758617T patent/PL1763363T3/pl unknown
- 2005-07-06 EP EP07101239A patent/EP1782824B1/de active Active
-
2006
- 2006-09-29 AT AT0162706A patent/AT503070B1/de not_active IP Right Cessation
-
2009
- 2009-08-20 HR HR20090447T patent/HRP20090447T1/hr unknown
- 2009-08-28 CY CY20091100902T patent/CY1109351T1/el unknown
-
2010
- 2010-08-24 US US12/862,379 patent/US8716244B2/en active Active
-
2014
- 2014-04-04 US US14/245,358 patent/US9364437B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090447T1 (hr) | Farmaceutski pripravci koji sadrže diaminooksidazu | |
| TWI574633B (zh) | 包含益生菌及益生質成分及礦物鹽及乳鐵蛋白之組合物 | |
| US9050323B2 (en) | Methods of treating destructive inflammation of the mucous membranes with lactoferrin | |
| US20100004183A1 (en) | Mineral collagen chelates and methods of making and using same | |
| CN109310653A (zh) | 用于控制释放半胱胺和系统治疗半胱胺敏感性病症的组合物 | |
| ES2932498T3 (es) | Composiciones que comprenden el péptido WKDEAGKPLVK | |
| HRP20160507T1 (hr) | Novi farmaceutski pripravak za preeklampsiju | |
| WO2006123248A3 (en) | Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject | |
| EA201590835A1 (ru) | Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием | |
| RU2008122368A (ru) | Композиция штаммов рода lactobacillus и применение композиции штаммов рода lactobacillus | |
| BRPI0418681A (pt) | um suplemento dietético para o tratamento e a prevenção de doenças do sistema digestivo e doenças relacionadas ao sistema digestivo e método de produção e administração deste | |
| ES2711427T3 (es) | Lactobacillus reuteri ATCC PTA 6475 para su uso en la prevención o el tratamiento de la pérdida ósea en mamíferos | |
| CN1961957A (zh) | 一种抗衰老结肠吸收制剂 | |
| RU2011124506A (ru) | Фармацевтический препарат, содержащий комбинацию штаммов streptococcus и штаммов lactobacillus | |
| CN102178167A (zh) | 茯苓营养挂面及制备方法 | |
| EP2597972A1 (en) | Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids | |
| MX2009004579A (es) | Composicion farmaceutica que tiene actividad antisicotica, antidepresiva o antiepileptica, con efecto colateral reducido. | |
| JP2014505679A5 (ja) | ||
| EP4058044A1 (en) | Treatment for inflammatory bowel disease and radiation-induced intestinal injury | |
| Ji et al. | Dietary intervention to reduce E. coli infectious diarrhea in young pigs | |
| WO2009019307A3 (en) | Oral calcitonin compositions and applications thereof | |
| RU2468812C2 (ru) | Средство, обладающее адаптогенным, тонизирующим и общеукрепляющим действием, и способ его получения | |
| KR20180125895A (ko) | 락토바실러스 sp. KCCM 11826P 균주를 이용한 요독물질 축적으로 말미암아 발생하는 질환의 개선, 예방 또는 치료용 조성물 | |
| AU2020364192B2 (en) | Gastrointestinal health composition | |
| TWI576117B (zh) | 玻尿酸產生促進劑 |